Does ANASTROZOLE Cause Product packaging quantity issue? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Product packaging quantity issue have been filed in association with ANASTROZOLE (Anastrozole). This represents 0.1% of all adverse event reports for ANASTROZOLE.
8
Reports of Product packaging quantity issue with ANASTROZOLE
0.1%
of all ANASTROZOLE reports
0
Deaths
1
Hospitalizations
How Dangerous Is Product packaging quantity issue From ANASTROZOLE?
Of the 8 reports, 1 (12.5%) required hospitalization.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ANASTROZOLE. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does ANASTROZOLE Cause?
Arthralgia (1,409)
Fatigue (1,215)
Nausea (1,049)
Malignant neoplasm progression (1,006)
Diarrhoea (851)
Metastases to bone (758)
Headache (725)
Dyspnoea (678)
Asthenia (649)
Dizziness (596)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which ANASTROZOLE Alternatives Have Lower Product packaging quantity issue Risk?
ANASTROZOLE vs ANDEXANET ALFA
ANASTROZOLE vs ANDROGEL
ANASTROZOLE vs ANETHOLTRITHION
ANASTROZOLE vs ANGIOTENSIN II
ANASTROZOLE vs ANHYDROUS CITRIC ACID\ASPIRIN\SODIUM BICARBONATE